» Articles » PMID: 37427304

Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation

Overview
Date 2023 Jul 10
PMID 37427304
Authors
Affiliations
Soon will be listed here.
Abstract

AF is the most common clinically relevant cardiac arrhythmia associated with multiple comorbidities, cardiovascular complications (e.g. stroke) and increased mortality. As artificial intelligence (AI) continues to transform the practice of medicine, this review article highlights specific applications of AI for the screening, diagnosis and treatment of AF. Routinely used digital devices and diagnostic technology have been significantly enhanced by these AI algorithms, increasing the potential for large-scale population-based screening and improved diagnostic assessments. These technologies have similarly impacted the treatment pathway of AF, identifying patients who may benefit from specific therapeutic interventions. While the application of AI to the diagnostic and therapeutic pathway of AF has been tremendously successful, the pitfalls and limitations of these algorithms must be thoroughly considered. Overall, the multifaceted applications of AI for AF are a hallmark of this emerging era of medicine.

Citing Articles

Performance of a medical smartband with photoplethysmography technology and artificial intelligence algorithm to detect atrial fibrillation.

Blok S, Gielen W, Piek M, Hoeksema W, Tulevski I, Somsen G Mhealth. 2025; 11:5.

PMID: 39944860 PMC: 11811644. DOI: 10.21037/mhealth-24-10.


Ablation Strategies for Persistent Atrial Fibrillation: Beyond the Pulmonary Veins.

Baqal O, Shafqat A, Kulthamrongsri N, Sanghavi N, Iyengar S, Vemulapalli H J Clin Med. 2024; 13(17).

PMID: 39274244 PMC: 11396655. DOI: 10.3390/jcm13175031.


Recent Advances in the Management of Non-rheumatic Atrial Fibrillation: A Comprehensive Review.

Kadam A, Kotak P, Khurana K, Toshniwal S, Daiya V, Raut S Cureus. 2024; 16(7):e65835.

PMID: 39219967 PMC: 11363501. DOI: 10.7759/cureus.65835.


Chemotherapy Related Cardiotoxicity Evaluation-A Contemporary Review with a Focus on Cardiac Imaging.

Scalia I, Gheyath B, Tamarappoo B, Moudgil R, Otton J, Pereyra M J Clin Med. 2024; 13(13).

PMID: 38999280 PMC: 11242267. DOI: 10.3390/jcm13133714.


Outcomes of Device-detected Atrial High-rate Episodes in Patients with No Prior History of Atrial Fibrillation: A Systematic Review and Meta-analysis.

Ahmed H, Ismayl M, Palicherla A, Kashou A, Dufani J, Goldsweig A Arrhythm Electrophysiol Rev. 2024; 13:e09.

PMID: 38984148 PMC: 11231819. DOI: 10.15420/aer.2024.11.


References
1.
Page R, WILKINSON W, Clair W, McCarthy E, Pritchett E . Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation. 1994; 89(1):224-7. DOI: 10.1161/01.cir.89.1.224. View

2.
Fine J, Branan K, Rodriguez A, Boonya-Ananta T, Ajmal , Ramella-Roman J . Sources of Inaccuracy in Photoplethysmography for Continuous Cardiovascular Monitoring. Biosensors (Basel). 2021; 11(4). PMC: 8073123. DOI: 10.3390/bios11040126. View

3.
Matsumoto T, Ehara S, Walston S, Mitsuyama Y, Miki Y, Ueda D . Artificial intelligence-based detection of atrial fibrillation from chest radiographs. Eur Radiol. 2022; 32(9):5890-5897. DOI: 10.1007/s00330-022-08752-0. View

4.
Khurshid S, Friedman S, Reeder C, Di Achille P, Diamant N, Singh P . ECG-Based Deep Learning and Clinical Risk Factors to Predict Atrial Fibrillation. Circulation. 2021; 145(2):122-133. PMC: 8748400. DOI: 10.1161/CIRCULATIONAHA.121.057480. View

5.
Pereira T, Tran N, Gadhoumi K, Pelter M, Do D, Lee R . Photoplethysmography based atrial fibrillation detection: a review. NPJ Digit Med. 2020; 3:3. PMC: 6954115. DOI: 10.1038/s41746-019-0207-9. View